{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:43:20Z","timestamp":1761129800652,"version":"3.41.0"},"reference-count":3,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>In pediatric ambulatory care, the speed of medication infusion can have major impact on healthcare staff workload and the number of children able to be treated by services designed to reduce inpatient length of stay. In many regions of the world, local and supraregional guidelines allow ceftriaxone infusions of \u226550 mg\/kg in infants and children up to 12 years of age to be given over 10 minutes. The generic European summary of product characteristics for ceftriaxone does not state a specific infusion time for this dose range, although 1 manufacturers\u2019 summary of product characteristics in the United Kingdom states a 30-minute minimum infusion time. We conducted a formal service evaluation of a change in practice at a large UK pediatric children\u2019s hospital and demonstrated the clinical feasibility, safety, and high parent satisfaction of 10-minute ceftriaxone infusions for prescribed doses \u226550 mg\/kg. This approach can improve patient flow within hospital-based ambulatory services as well as by community nursing teams administering antibiotics at home.<\/jats:p>","DOI":"10.1097\/inf.0000000000002923","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T09:08:54Z","timestamp":1604912934000},"page":"128-129","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating Ceftriaxone 80 mg\/kg Administration by Rapid Intravenous Infusion\u2014A Clinical Service Evaluation"],"prefix":"10.1097","volume":"40","author":[{"given":"Sanjay","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Paediatric Immunology & Infectious Diseases"},{"name":"NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology & Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology & Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Rutter","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology & Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Bevan","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology & Infectious Diseases"},{"name":"Pharmacy Department, University Hospital Southampton NHS Foundation Trust"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran","family":"Hand","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Jones","sequence":"additional","affiliation":[{"name":"NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre"},{"name":"Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[{"name":"NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre"},{"name":"Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1097\/INF.0000000000002031","article-title":"The impact of pediatric outpatient parenteral antibiotic therapy implementation at a tertiary children\u2019s hospital in the United Kingdom.","volume":"37","author":"Patel","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/archdischild-2015-309731","article-title":"The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.","volume":"101","author":"Hodgson","year":"2016","journal-title":"Arch Dis Child"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2005.08.005","article-title":"Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.","volume":"26","author":"Goldwater","year":"2005","journal-title":"Int J Antimicrob Agents"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:05:14Z","timestamp":1750003514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002923","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2020,10,26]]}}}